Use with caution and monitor for the effects below.
Generally well-tolerated and a recommended combination for hard-to-control hypertension. Watch for symptomatic low blood pressure (dizziness, fainting on standing), pronounced bradycardia (resting heart rate <50), and ankle swelling (an amlodipine class effect that beta blockers do not blunt).
Why this happens (mechanism)
Amlodipine is a dihydropyridine calcium channel blocker that lowers blood pressure by relaxing arteries. Metoprolol is a beta blocker that slows the heart and reduces contractility. The two are commonly co-prescribed to control hypertension, but their effects on blood pressure and heart rate are additive — most patients tolerate it well, but some get symptomatic.
What to monitor
- Blood pressure (sitting AND standing) — orthostatic drops are the most common complaint
- Resting heart rate; flag if <50 bpm or symptomatic
- New or worsening ankle swelling
- Symptoms of fatigue or exertional intolerance after starting
Dose adjustment
Start each at a low dose and titrate. If symptomatic hypotension or bradycardia develops, reduce one drug rather than stopping both. No specific cross-titration warning beyond that.
Safer alternatives to consider
Often a better second-line choice when heart-rate control is not the goal; complementary mechanism with amlodipine.
Common third-line agent that adds blood-pressure lowering without overlapping with the calcium channel blocker.
Always discuss alternatives with your prescriber before making any change. The right choice depends on your other medications, conditions, and what is working for you today.